We made non-substantive typographical corrections and the following substantive changes to the original figure of our editorial “DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome”1: WHO 2nd edition 2001 is changed to WHO 3rd edition 2001; WHO 3rd edition 2008 is changed to WHO 4th edition 2008; and WHO 4th edition 2016 is changed to WHO Revised 4th edition 2016.
References
- 1.Savage KJ, Slack GW. DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome. Haematologica. 2023;108(6):1463-1467. [DOI] [PMC free article] [PubMed] [Google Scholar]